Effectiveness and Implications of Alternative Placebo Treatments
2015/07/27 by Raveendhara R. Bannuru, Timothy E. McAlindon, Matthew C. Sullivan +3 · 25 citations
Neuroscience · Medicine · #Pain Management and Placebo Effect #Acupuncture Treatment Research Studies #Complementary and Alternative Medicine Studies
paper · doi:10.7326/m15-0623
Abstract
BACKGROUND: Placebo controls are essential in evaluating the effectiveness of medical treatments. Although it is unclear whether different placebo interventions for osteoarthritis vary in efficacy, systematic differences would substantially affect interpretation of the results of placebo-controlled trials. OBJECTIVE: To evaluate the effects of alternative placebo types on pain outcomes in knee osteoarthritis. DATA SOURCES: MEDLINE, EMBASE, Web of Science, Google Scholar, and Cochrane Database from inception through 1 June 2015 and unpublished data. STUDY SELECTION: 149 randomized trials of adults with knee osteoarthritis that reported pain outcomes and compared widely used pharmaceuticals against oral, intra-articular, topical, and oral plus topical placebos. DATA EXTRACTION: Study data were independently double-extracted; study quality was assessed by using the Cochrane risk of bias tool. DATA SYNTHESIS: Placebo effects that were evaluated by using a network meta-analysis with 4 separate placebo nodes (differential model) showed that intra-articular placebo (effect size, 0.29 [95% credible interval, 0.09 to 0.49]) and topical placebo (effect size, 0.20 [credible interval, 0.02 to 0.38]) had significantly greater effect sizes than did oral placebo. This differential model showed marked differences in the relative efficacies and hierarchy of the active treatments compared with a network model that considered all placebos equivalent. In the model accounting for differential effects, intra-articular and topical therapies were superior to oral treatments in reducing pain. When these differential effects were ignored, oral nonsteroidal anti-inflammatory drugs were superior. LIMITATIONS: Few studies compared different placebos directly. The study could not decisively conclude whether disease severity and co-interventions systematically differed between trials evaluating different placebos. CONCLUSION: All placebos are not equal, and some can trigger clinically relevant responses. Differential placebo effects can substantially alter estimates of the relative efficacies of active treatments, an important consideration for the design of clinical trials and interpretation of their results. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.
Cited by
- Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials. [europepmc]
- To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. [europepmc]
- Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. [europepmc]
- The magnitude and temporal changes of response in the placebo arm of surgical randomized controlled trials: a systematic review and meta-analysis. [europepmc]
- Expectations about the effectiveness of pain- and itch-relieving medication administered via different routes. [europepmc]
- Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain. [europepmc]
- Efficacy of curcumin and Boswellia for knee osteoarthritis: Systematic review and meta-analysis. [europepmc]
- What Is the Role of the Placebo Effect for Pain Relief in Neurorehabilitation? Clinical Implications From the Italian Consensus Conference on Pain in Neurorehabilitation. [europepmc]
- Intra-articular treatment options for knee osteoarthritis. [europepmc]
- Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study. [europepmc]
- Intra-Articular Hyaluronic Acid in the Symptomatic Treatment of Knee Osteoarthritis: A Meta-Analysis of Single-Injection Products. [europepmc]
- Meta-analysis of pain and function placebo responses in pharmacological osteoarthritis trials. [europepmc]
- A tale of two TrkA inhibitor trials: same target, divergent results. [europepmc]
- A Comparison of Treatment Effects for Nonsurgical Therapies and the Minimum Clinically Important Difference in Knee Osteoarthritis: A Systematic Review. [europepmc]
- A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial. [europepmc]
- Differentiating factors of intra-articular injectables have a meaningful impact on knee osteoarthritis outcomes: a network meta-analysis. [europepmc]
- Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial. [europepmc]
- Is There Any Role for Opioids in the Management of Knee and Hip Osteoarthritis? A Systematic Review and Meta-Analysis. [europepmc]
- Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials. [europepmc]
- Placebo Effects in Acupuncture. [europepmc]
- The roles of expectation, comparator, administration route, and population in open-label placebo effects: a network meta-analysis. [europepmc]
- Assessment of Pain in Osteoarthritis of the Knee. [europepmc]
- Placebo effects in osteoarthritis: implications for treatment and drug development. [europepmc]
- Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. [europepmc]
- CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. [europepmc]
Related